Serum calprotectin is a marker of disease activity in Giant cell arteritis

被引：4

作者：

Saut, Antoine ^{[1
,4
]}

Pacletb, Marie-Helene ^{[2
,3
]}

Trocme, Candice ^{[3
]}

Toussaint, Bertrand ^{[2
,3
]}

Bocquet, Alexis ^{[1
]}

Bouillet, Laurence ^{[1
,2
]}

Baillet, Athan ^{[2
]}

机构：

[1] Grenoble Alpes Univ Hosp, Internal Med Dept, Grenoble Alpes, France

[2] Univ Grenoble Alpes, TIMC, Grenoble INP, VetAgro Sup,CNRS,UMR 5525,CHU Grenoble Alpes, Grenoble, France

[3] CHU Grenoble Alpes, Dept Biol, La Tronche, France

[4] Grenoble Univ Hosp, Internal Med Dept, CS10217, F-380430 Grenoble 9, France

来源：

关键词：

Giant cell arteritis; Calprotectin; Biomarker; Disease activity; Anti-interleukin; 6;

D O I：

10.1016/j.autrev.2023.103469

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

引用

页数：2

共 50 条

[31] The relationship between serum calprotectin levels and disease activity in patients with subacute thyroiditis
Cengiz, H.
Demirci, T.
Varim, C.
Gonullu, E.
EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2021, 25 (10) : 3745 - 3751
[32] Giant cell arteritis
Penn, H
Dasgupta, B
AUTOIMMUNITY REVIEWS, 2003, 2 (04) : 199 - 203
[33] Giant Cell Arteritis
Smith, Jonathan H.
Swanson, Jerry W.
HEADACHE, 2014, 54 (08): : 1273 - 1289
[34] Giant cell arteritis
Czihal, M.
Hoffmann, U.
GEFASSCHIRURGIE, 2019, 24 (02): : 128 - 134
[35] Serum calprotectin and ischemia modified albumin levels as markers of disease activity in Behcet's disease
Omma, Ahmet
Sandikci, Sevinc Can
Colak, Seda
Tecer, Duygu
Yucel, Cigdem
Ozbalkan, Zeynep
POSTEPY DERMATOLOGII I ALERGOLOGII, 2018, 35 (06): : 609 - 613
[36] Giant cell arteritis
Joshua A. Beckman
Current Treatment Options in Cardiovascular Medicine, 2000, 2 (3) : 213 - 218
[37] Giant cell arteritis
Wang, Xiang
Hu, Zhi Ping
Lu, Wei
Tang, Xiang Q.
Yang, He P.
Zeng, Liu W.
Zhang, Jie
Li, Ting
RHEUMATOLOGY INTERNATIONAL, 2008, 29 (01) : 1 - 7
[38] Giant Cell Arteritis
Vgontzas, Angeliki
Papke, David J., Jr.
Bernstein, Carolyn A.
HEADACHE, 2018, 58 (06): : 883 - 884
[39] Giant cell arteritis
Roger E. Turbin
Mark J. Kupersmith
Current Treatment Options in Neurology, 1999, 1 (1) : 49 - 56
[40] The Immunopathology of Giant Cell Arteritis Across Disease Spectra
Robinette, Michelle L.
Rao, Deepak A.
Monach, Paul A.
FRONTIERS IN IMMUNOLOGY, 2021, 12